background: Deleted in AZoospermia-like (DAZL) is an autosomal homologue of Y chromosome-linked DAZ gene located on chromosome 3p24. DAZL is only expressed in the gonads and is critical to germ cell development in different species. However, the regulation of DAZL has not been explored.
Introduction
The World Health Organization (WHO) has defined infertility as inability of the couple to conceive after 2 years of unprotected sexual activity. It affects 15% of couples in Western countries and has become an equally important problem in the Eastern countries (De Kretser, 1997; Evers, 2002) . In roughly half of the infertile with markers on the long arm of the human Y chromosome has detected Yq microdeletions in 5 -15% of males with spermatogenic failure. On the euchromatic Y chromosome, the DAZ (Deleted in AZoospermia) gene was the first to be identified as a Y-chromosomal sterility gene Vogt et al., 1996; McElreavey and Krausz, 1999) . The DAZ gene has an autosomal homolog, DAZL (DAZ-Like), on chromosome 3p24. It is believed that the DAZ gene arose 40 million years ago from the transposition, repeat amplification and pruning of an ancestral autosomal gene DAZL during primate evolution (Saxena et al., 1996; Shan et al., 1996; Yen et al., 1996) .
DAZL is critical to germ cell development in different species. In Xenopus, Xdazl is required for early primordial germ cell differentiation and is indirectly necessary for the migration of primordial germ cells through the endoderm (Houston and King, 2000) . In mice, the loss of function of the DAZL homologue leads to the loss of germ cells in both sexes (Ruggiu et al., 1997) . In humans, we have identified a single-nucleotide polymorphism (SNP) of DAZL, 386 A.G, which confers susceptibility to severe spermatogenic failure (sperm concentrations ,2 × 10 6 /ml) in Han Taiwanese men .
Later, we found that specific DAZL haplotypes were related to severe spermatogenic failure (Teng et al., 2006) . Given the absence of 386 A.G SNP in other ethnic groups, 386 A.G seems to be restricted to the Taiwanese Han population (Becherini et al., 2004; Tschanter et al., 2004; Yang et al., 2005; Thangaraj et al., 2006) . DAZL is only expressed in the gonads, but how this gene is regulated at the transcriptional level remains obscure. In this study, we set out to identify the core promoter region of DAZL and to identify regulatory SNPs which may be related to male infertility. Several novel SNPs in the promoter region of DAZL were identified. Of these SNPs, 2792G.A was more prevalent in infertile men with spermatogenic failure than in fertile men with normal semen parameters. Quantitative trait analysis showed that the 2792A allele is associated with decreased sperm concentrations and poor sperm motility. We also found that the G to A substitution may interfere with binding of nuclear respiratory factor-1 (NRF-1) to the promoter region. To the best of our knowledge, this is the first report on the association of a DAZL promoter SNP with spermatogenic failure.
Materials and Methods

Subjects
The study was approved by the Institutional Review Board (IRB) of the National Cheng-Kung University Hospital and Lee Women's Hospital. From August 2006 to July 2008, a total of 337 infertile men presenting with azoospermia or oligozoospermia (sperm concentration ,20 × 10 6 /ml) were recruited to the study. We also enrolled 203 fertile men with normal semen parameters as control subjects. All of the control subjects had fathered at least two children without assisted reproductive technologies. Informed consents were obtained from all enrollees. All study and control subjects belonged to Han Taiwanese population, the major ethnic group in Taiwan (making up more than 95% of the country's population). All patients underwent comprehensive surveillance according to the protocols described in our previous studies, including a detailed history taking, physical examination, semen analyses, endocrinology profiles testing (luteinizing hormone, follicular-stimulating hormone, prolactin and testosterone), karyotyping and a molecular test for Y-chromosome microdeletions Teng et al., 2002 Teng et al., , 2006 Teng et al., , 2007 . Semen analysis was performed according to the protocol recommended by the WHO using a modified Neubauer chamber (World Health Organization, 1992) . The semen samples were collected after a minimum of 2 days and a maximum of 7 days of sexual abstinence. Molecular analysis of Ychromosome microdeletions included a combination of five gene-based markers as described previously (Teng et al., 2007) . Subjects with recognizable causes of male infertility were excluded from the screening; these included varicocele, hypogonadotropic hypogonadism, toxic habits (tobacco, alcohol or drug use), occupational exposures, previous treatments (immuno-therapy, cancer therapy or hormone therapy), unilateral orchidectomy, vasectomy, cryptorchidism and chronic genital infections. Cases with an abnormal karyotype or Y chromosomal microdeletion were also excluded.
Prediction of the promoter region and transcription factor binding
The following websites were used to predict the regulatory element of DAZL: Promoter Scan (P2) (http://thr.cit.nih.gov/molbio/proscan/); Promoter 2.0 Prediction Server (PP) (http://www.cbs.dtu.dk/services/ Promoter/); Berkeley Drosophila Genome Project (McP) (http://www. fruitfly.org/seq_tools/promoter.html); DBTSS (http://dbtss.hgc.jp/index. html); and Prediction of CpG island (CPG) (http://www.ebi.ac.uk/ emboss/cpgplot/). The Transcription Element Search System (http: //www.cbil.upenn.edu/cgi-bin/tess/tess) was used to predict the binding of transcription factors (TFs).
Genotyping
Genomic DNA was extracted from peripheral blood samples using a Puregene DNA isolation kit (Gentra, Minneapolis, MN, USA). Genomic DNA samples were subjected to sequence analysis for the promoter region of DAZL. Polymerase chain reactions (PCRs) were used to amplify the DAZL promoter region. The primer sequences were as follows: human DAZL1 forward 5 ′ -GGGGTACCGTGATGGCGCTAACCCTGTGCCTT AG-3 ′ and reverse 5 ′ -GAAGATCTCCACACGAGGGAGCCGCCAT-3 ′ ; GAPDH forward 5 ′ -TGAAGGTCGGAGTCAACGGATT-3 ′ and reverse 5 ′ -CCTGGAAGATGGTGATGGGATT-3 ′ . The PCR consisted of 35 cycles of gene amplification as follows: 958C for 30 s, 65 -688C for 30 s and 728C for 1 min. The PCR products were resolved by using electrophoresis on 1% agarose gels and the appropriate band was excised and purified for the subsequent steps of cloning or sequence determination. Sequence analysis was performed with an automatic sequencer (ABI 377, Applied Biosystems/PE).
Sodium bisulfite treatment and sequence analysis
Reactions for sodium bisulfite treatment were carried out using standard conditions of the EZ DNA methylation kit (ZYMO RESEARCH, Irvine, CA, USA). DNA was dissolved in 40 ml water and used immediately for PCR amplification or stored at 2208C. Primers were designed using Methprimer (Li and Dahiya, 2002) to distinguish methylated and unmethylated DNA after bisulfate treatment of the template. The sequence of the forward primers was 5 ′ -TTGTGTTTTAGAGAAGTTATTTGGAAAT-3 ′ ; and reverse primer was 5 ′ -ACCACTTCTAAAACTACTATAAAATCC-3 ′ . The PCR conditions included initial denaturing at 958C for 5 min, followed by 40 cycles of amplification consisting of denaturation at 958C for 30 s, annealing at 558C for 90 s and elongation at 728C for 2 min. The Gel-M Gel Extraction Miniprep System (Viogene, Cat No. EG1001) was used for extraction of the DNA fragment, which was then cloned into PGEAM T easy vector (Promega Corp., Madison, WI, USA). At least 20 colonies were randomly chosen for sequencing.
Plasmid construction
Reporter plasmids were constructed by inserting various lengths of the 5 ′ -upstream region of the human DAZL gene between the NheI and HindIII sites of the pGL3-Basic Vector (Promega Corp.). An 1 kb fragment of the DAZL promoter spanning nucleotides 2993 to +52 (2993/+52) was subcloned into the firefly luciferase reporter pGL3-Basic vector lacking the promoter (Promega Corp.). The deletion constructs (2993/+52, 2733/+52, 2473/+52, 2204/+52) were generated by PCR. The fidelity of all constructs created was confirmed by nucleotide sequence analysis.
Site-Directed Mutagenesis
The QuikChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA) was used to introduce mutations into the 2792G-LUC and 2792A-LUC DAZL promoter construct according to the manufacturer's instructions. The negative control was the DAZL gene promoter region with the NRF-1-binding site deleted. The presence of the mutations was confirmed by both restriction enzyme digest and sequencing analysis.
Transient transfection and luciferase reporter gene assay
For the reporter gene assay, HeLa and GC1 cells (1.5 × 10 5 cells) were seeded into 2 ml medium containing 7% (v/v) FBS in each well of a 6-well culture plate, and then cultured for 24 h. Lipofectamine reagent (Invitrogen, Carlsbad, CA, USA) was used for transfection (duplicate) of plasmid DNA [reporter plasmid (0.5 mg) and pRL-TK vector (0.5 mg)
per well], according to the manual supplied by the manufacturer, except that the volume was quadrupled. Lysis buffer (90 ml) was added to the phosphate-buffered saline [10 mM sodium phosphate buffer (pH 7.2), 137 mM NaCl, 3 mM KCl] (PBS)-washed plate 48 h after the start of transfection, and a cell lysate was prepared (12 000g, 10 min at 48C). An aliquot (20 and 5 ml) of the supernatant was used for measurement of the luciferase activities. The pRL-TK vector (Promega Corp.) containing the Renilla luciferase gene under control of the thymidine kinase promoter was used as a control. Reporter activity was normalized by calculating the ratio of firefly/Renilla values.
Electrophoretic mobility shift assay (EMSA)
Bandshift assays were carried out according to standard protocols. Briefly, a reaction mixture containing 5 mg of HeLa cell or GC1cell nuclear extract, 1 -1.5 mg/ml of poly(dI-dC), 100 mg/ml of bovine serum albumin, 16 mM HEPES (pH 7.9), 120 mM KCl, 4 mM EDTA, 0.8 mM DTT, 0.06% NP-40 and 6% Ficoll 400, with or without non-labeled competitor oligonucleotides at a 25 -200-fold molar ratio against the labeled probe, was incubated for 10 min at room temperature. The labeled probe of 1 × 10 4 cpm was then added to the mixture, and the mixture was further incubated at room temperature for 30 min. DNA -protein complexes formed in the mixture were separated in a 4.5% polyacrylamide gel containing 0.25× TBE and visualized by autoradiography. For a supershift experiment, a plasmid containing the Myc-tagged full-length NRF-1 was transfected into HepG2 cells. The nuclear extract was first incubated with various amounts of anti-Sp1 antibody, anti-NRF-1 antibody or serum IgG at 08C for 60 min, and then the reaction was carried out as described above after the mixture without the nuclear extract was added back to this mixture. Nucleotide sequences of the upper strand of NRF-1 and mutant-NRF-1 oligonucleotides were 5
Statistics
Association tests for allelic and genotypic frequencies were performed using the x 2 test or Fisher exact test by GraphPad Prism 5.0. The risk of spermatogenic failure was estimated using logistic regression to report odds ratios (ORs) and 95% confidence interval (CI). Among the four markers, only 2792 G.A exhibited significant association with spermatogenic failure. We further conducted quantitative trait analyses to evaluate the distributions of the three sperm parameters in relation to this polymorphic locus. Log-transformed sperm concentration (×10 6 /ml), motility and morphology were analyzed using PLINK (Purcell, http://pngu.mgh.harvard.edu/~purcell/plink/) for the 2792 G.A polymorphism. In addition to allelic test, we employed genotypic tests with an additive model and reported the mean (+SD) of the three sperm parameters by genotype. We used regression-based models, which were implemented in PLINK to calculate the effect size and significance level for each marker with quantitative traits. Because the results from the regression models with or without age adjustment were very similar, we only presented quantitative analysis results with age adjustment. Violation of Hardy -Weinberg equilibrium (HWE) was also tested via the PLINK with a threshold of 0.05. A nominal P value of ,0.01 was set as the threshold for claiming statistical significance in both binary trait and quantitative analysis for sperm parameters.
Results
Semen parameters
The age was matched between infertile men and fertile controls (31.31 + 3.98 vs 31.30 + 3.92, P . 0.05). Table I shows the ages as well as the three major semen parameters of patients and fertile controls.
Identification of the core promoter and CpG islands of human DAZL
In-silicon searches showed that the DAZL promoter was located about 1 kb upstream of the transcription start site (TSS Information (NCBI) database (NM_001190811.1 for transcript variant 1 and NM001351.3 for transcript variant 2); in this study, the TSS was determined according to NM_001190811.1. The putative promoter region was divided into four subregions. Each subregion was PCR amplified and subcloned into the reporter vector (pGL3 basic vector) (Fig. 1A) . The results of the dual luciferase reporter assay are shown in Fig. 1B and C. We found that all four fragments were associated with increased luciferase activities. The 2993/+52 and 2808/+52 fragments caused the highest activities; in comparison the promoter sequence up to 2473 resulted in reduced luciferase activity. Interestingly, a truncation of the promoter at 2808 instead of 2993 resulted in a substantial increase in the promoter activity in GC1 cells. We suggest that the DAZL core promoter is located in the region from 2808 to 2473 from the TSS. The CpG islands are located approximately between positions 2865 and 2461 from the TSS (Supplementary Fig. 1A) . A total of 40 CpG sites were located within the predicted CpG islands (total length 405 bp) ( Supplementary  Fig. 1B ). We also found that the DAZL promoter is frequently hypermethylated in normal blood cells but hypomethylated in the spermatozoa ( Supplementary Fig. 2 ).
Regulatory SNPs conferring susceptibility to spermatogenic failure in Taiwanese men
We systematically sequenced up to 1 kb upstream of the DAZL TSS. Three SNPs (2792G.A, 2669A.C and 2309T.C) were identified in both fertile men and infertile men (Fig. 2) . Of these three SNPs, two (2669A.C and 2309T.C) have not been reported in databases or in the literature. The allelic and genotypic frequencies of these three SNPs are shown in Table II . Of the three SNPs, A was significantly associated with spermatogenic failure (P ¼ 0.0005) with an OR of 8.13 (Table II) . Even using the more stringent Bonferroni correction (a ¼ 0.05/3 ¼ 0.0167), the significant finding still holds for 2792G.A (P ¼ 0.0005). We further conducted 5000 permutations to obtain an empirical P-value for this marker, and the P-value was 0.0006, which is still significant. Fisher's exact test showed that all SNPs were in HWE. The OR for each genetic homozygote variants is shown in SNP 2792G>A decreases DAZL transcription by affecting NRF-1 binding
To investigate whether the nucleotide substitution of G by A would modify binding affinity of the promoter with nuclear proteins, EMSA was performed by incubating nuclear protein extracts of HeLa and GC1 cells with double-stranded oligonucleotide probes containing either wild-type (G) or mutant (A) allele. Using the DNA -EMSA, we found that 2792G.A (rs2241533) appeared to affect the binding of nuclear proteins from the GC1 cells (Fig. 3A) . GC1 is a mouse type B spermatogonia cell line and was found to have endogenous dazl expression (data not shown).
Binding by NRF-1 was confirmed by the supershift assay using HepG2 cells over-expressing the Myc-tagged NRF-1. The signal for the DNA -protein complex containing the NRF-1-myc fusion protein was reduced by the monoclonal anti-Myc antibody. Considering NRF-1 usually binds to the GC-rich region in the promoter and usually interacts with other TFs, such as Sp1, for transcriptional regulation, we used unlabeled NRF-1 and Sp1 antibodies for the competition experiments. The DNA-protein complex was competed by NRF-1 antibody (Fig. 3B, lane 4) , but not by serum IgG and SP1 antibody (Fig. 3B, lane 3 and 5) . 
Functional significance of 2792A
The HeLa (Fig. 4) and GC1 (Fig. 4B ) cells transfected with 2792G allele had a 1.5-to 2-fold increase in reporter gene activity as compared with the 2792A allele, respectively. The result indicates that the G to A substitution decreases transcriptional activity of DAZL.
We therefore further explored the association between 2792G.A genotypes and three major semen parameters. Quantitative trait analysis showed that the 2792A allele is negatively associated with sperm concentrations and sperm motility in both control subjects and patients. The two groups were pooled for analysis and the results are shown in Table IV .
Discussion
NRF-1 is a TF that acts on nuclear genes encoding respiratory subunits and components of the mitochondrial transcription and replication machinery (Gopalakrishnan and Scarpulla, 1995; Moraes, 2001 ). The NRF-1-binding site is one of the most abundant binding sites specific to the spermatogonia stage by transcriptional and biological network analysis. Although previous studies do not directly show that NRF-1 is involved in regulating germ-line-specific genes, it is reasonable to speculate NRF-1 may play an important role in spermatogenesis (Lee et al., 2006) . In this report, we provide direct evidences that NRF-1 is involved in transcriptional regulation of DAZL, a human sterility gene.
There is a growing consensus that gene expression changes are likely to play an important role in human phenotypic variation and in disease predisposition (Pastinen and Hudson, 2004; Chen et al., 2006; Khaitovich et al., 2006) complex disease. Spermatogenic failure is a complex disease with multiple environmental and genetic factors contributing to its pathogenesis (Shah et al., 2003; Ferlin et al., 2007; Tuttelmann et al., 2007; Poongothai et al., 2009) . The information available on how human genetic variation affects expression levels and how genetic information is translated into phenotypic variation in spermatogenesis is very limited. In this study, we found three SNPs located in the DAZL promoter region in our population. Of these three SNPs, 2792G.A was significantly associated with spermatogenic failure. We demonstrated that 2792A affects transcriptional activity and binding of nuclear proteins. It is noteworthy that 2792G.A is located within the CpG islands. We reason that the G to A substitution can reduce DAZL expression by interfering with transcriptional factor binding, particularly that of NRF-1. We also showed the 2792A allele is negatively correlated with sperm concentration and sperm motility. This finding is in accord with our previous report that DAZL is involved in regulating both sperm concentration and motility (Hsu et al., 2010) . Dazl has been demonstrated to have functions in maintenance of pluripotency and epigenetic programs of differentiation in mouse PGCs (Haston et al., 2009) . Deletion of mouse Dazl results in loss of male primordial germ cells at the embryonic stage or arrest of spermatogenesis at meiotic prophase 1 (Lin and Page, 2005; Ruggiu et al., 1997) . It is not surprising that DAZL gene dysfunction may decrease sperm concentrations. DAZL may also regulate sperm motility through its effect on Tssk2, a testis-specific kinase bound with both human DAZL and mouse Dazl, which in turn regulates SPAG16L, the sperm axoneme central apparatus protein necessary for flagella motility and sperm motility (Zhang et al., 2006 Zeng et al., 2008) . DAZL encodes a germ-cell-specific RNA-binding protein, which may be involved in post-transcriptional regulation of many substrate genes during spermatogenesis (Reynolds and Cooke, 2005) . Although DAZL expression is highly regulated in the germ-cell lineages, the element that contributes to this exquisite expression has not been fully elucidated. In this study, about 500 bp sequences (2473 to 2993) upstream of the human DAZL TSS was identified as having strong promoter activity. In the mouse, a 1.7 kb sequence in the 5 ′ flanking region of the mouse Dazl gene has been shown to be sufficient to drive robust germ cell-specific expression of green fluorescent protein in adult testis, with lower levels of expression in the adult ovary and fetal and newborn gonads of both sexes (Nicholas et al., 2009) . Comparison of genomic regions upstream of the TSS in mouse and human Dazl genes showed poor conservation of DNA Figure 4 The NRF-1-binding site is important for DAZL promoter activity. Human HeLa cells (A) and GC1 cell (B) were transiently transfected with luciferase reporter plasmids (1 or 2 mg) driven by either no promoter (pGL2Basic), or the DAZL promoter fragments containing 2792G, or 2792A. ***P , 0.0001. sequences (data not shown). Although ultra-conserved non-coding DNA may suggest selective constraints or purifying selection, divergent DNA sequences do not necessarily imply functional dispensability or redundancy (Dermitzakis et al., 2005; McLean and Bejerano, 2008; Visel et al., 2009; Pennacchio and Visel, 2010) . It remains to be explored whether human DAZL and mouse Dazl are subjected to similar regulatory mechanisms. Genome-wide analysis suggests that tissue-specific differentially methylated regions may play a role in cellular identity and the regulation of tissue-specific function (Song et al., 2005 (Song et al., , 2009 Ohgane et al., 2008; Rakyan et al., 2008; Chatterjee et al., 2011) . Genome-wide analysis has also shown a distinctive methylation status of testicular DNA in germ, when compared with somatic, cells (Oakes et al., 2007) . Methylated DNA may also be bound by proteins known as methyl-CpG-binding domain (MBD) proteins. MBD proteins then recruit additional proteins to the locus, such as histone deacetylases and other chromatin remodeling proteins thereby to form compact, inactive chromatin (Robertson, 2005) . Germ cell-specific genes (e.g. Mvh, Dazl and Scp3) are usually silenced by DNA methylation in both pre-migratory germ cells and somatic cells, but not in postmigratory germ cells (Maatouk et al., 2006) . In this study, we found that the CpG islands of the DAZL promoter is hypermethylated in the somatic cells, a finding in accord with previous reports (Chai et al., 1997; Navarro-Costa et al., 2010) . The 5 ′ end of DAZL and DAZ genes are hypomethylated in spermatozoa but not in leukocytes or placenta, consistent with the expression pattern of the genes (Chai et al., 1997) . In vitro methylation of a reporter construct corresponding to these 149 bp resulted in complete suppression of porcine DAZL promoter activity in primordial germ cells, further supporting a role for methylation in regulating porcine DAZL expression (Linher et al., 2009) . It has yet to be explored how CpG islands of the DAZL promoter are methylated in somatic cells while de-methylated in the germline. By using ejaculated sperm from olio-asthenoteratozoospermic (OAT) men, Navarro-Costa et al. showed there are 31 CpGs for DAZL, a number slightly lower our study. They also found disrupted DNA methylation of DAZL in OAT men. Their finding provided a link between incorrect epigenetic marks of sterile genes and male gametogenic defects. However, aberrant DNA methylation of the DAZL promoter may be a phenomenon secondary to abnormal spermatogenesis, instead of the cause of the spermatogenic defect considering that many genes may be dys-regulated in the poorquality sperm (Garrido et al., 2009; García-Herrero et al., 2010; Navarro-Costa et al., 2010) . We tend to believe that 2792G.A is a bona fide regulatory SNP, which predispose patients with the A allele to spermatogenic failure by decreasing DAZL expression. Two DAZL transcripts have been identified in the database: NM_001190811.1 for transcript variant 1 and NM001351.3 for transcript variant 2. The distance between the TSS's of these two transcripts is 709 bp. In this study, TSS and SNP locations were determined according to the transcript variant 1. Thus functional validation of the 2792A allele could be only applicable to the transcript variant 1. Nevertheless, these two transcripts seem to share the same CpG islands, considering no difference in the CpG islands' location between Navarro-Costa's study (Navarro-Costa et al., 2010) and ours ( Supplementary Fig. 3 ). The differences in expression patterns, regulatory mechanisms and functions of the two DAZL transcripts await further investigation. Our study provides strong evidence for an association of a DAZL promoter polymorphism with spermatogenic failure. We also provide the first clue about regulatory mechanisms of DAZL. Of 49 DAZL promoter SNPs in the database (http://www.ncbi.nlm.nih. gov/SNP/), only one SNP (2792A.G) was identified in the Taiwanese Han population. We also found three novel SNPs, making the total number of DAZL promoter SNPs add to 51. It would be necessary to replicate our findings in different ethnic groups. Our report also adds 2792G.A to the growing list of regulatory SNPs in spermatogenic failure. Indeed, only a limited number of regulatory SNPs have been reported to be associated with male infertility, including protamine genes, human follicle-stimulating hormone receptor gene, estrogen receptor alpha \xEF\x80gene and tumor necrosis factoralpha gene (Wunsch et al., 2005; Guarducci et al., 2006; Gazquez et al., 2008; Tronchon et al., 2008 the regulatory mechanism of human DAZL. Of 51 DAZL promoter SNPs available at the present time, two SNPs (rs2241532 and rs36004482) are expected to be located in the SP1-binding sites (the Transcription Element Search System, http://www.cbil.upenn. edu /cgi-bin/tess/tess). NRF-1 usually corroborates with other TFs for transcriptional regulation. FMR-1 is mainly expressed in the brain and germ-line and NRF-1 and Sp1 have been shown to be strong, synergistic activators of an unmethylated human FMR1-driven reporter (Smith et al., 2004) . Herein, we provide preliminary evidence for the role of a novel SNP in the DAZL promoter in human spermatogenic failure. Further studies are required to explore whether NRF-1 corroborates with Sp1 or other TFs to regulate DAZL.
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